Article info
PDFClinical and epidemiological research
Extended report
Responsiveness of disease activity indices ESSPRI and ESSDAI in patients with primary Sjögren's syndrome treated with rituximab
- Correspondence to A Vissink, Department of Oral and Maxillofacial Surgery, University Medical Center Groningen, P O Box 30.001 9700 RB, Groningen, The Netherlands; a.vissink{at}kchir.umcg.nl
Citation
Responsiveness of disease activity indices ESSPRI and ESSDAI in patients with primary Sjögren's syndrome treated with rituximab
Publication history
- Received July 15, 2011
- Accepted December 11, 2011
- First published January 17, 2012.
Online issue publication
July 14, 2012
Article Versions
- Previous version (17 January 2012).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions